---
figid: PMC2861144__nihms195501f1
figlink: /pmc/articles/PMC2861144/figure/F1/
number: F1
caption: 'Potential targets for inhibition are depicted in light gray boxes. Potential
  inhibitors are depicted in clear boxes. The cAMP pathway promotes cell proliferation
  and fluid secretion in PKD. cAMP leads to fluid secretion via the CFTR. cAMP results
  in activation of the ERK-MAPK pathway leading to cell proliferation. cAMP accumulation
  is promoted by mechanisms of dysregulation of PC1 or PC2, as well as inhibition
  of Ca2+-dependent phosphodiesterase (PDE). Caffeine inhibits PDE, which normally
  degrades cAMP. Thus, caffeine results in an increase in cAMP. cAMP signaling also
  requires PKA, Src and Ras. Src is known to activate Ras. Activation of tyrosine
  kinase receptors also contributes to the stimulation of MAPK-ERK signaling with
  consequent cell proliferation. Potential therapeutic targets are the vasopressin
  V2 receptor, tyrosine kinases, MEK and c-Src. The PI3K-Akt pathway plays a major
  role in mTOR signaling (see ); mTOR inhibitors bind to FKBP, which subsequently
  inhibits mTOR. There is evidence for activation of the mTOR pathway in ADPKD. The
  RAAS (see ) is activated by a drop in renal perfusion that stimulates the JGA to
  make renin. ACE inhibitors block the conversion of angiotensin I to angiotensin
  II. Renin inhibitors directly block renin production by the JGA. Angiotensin receptor
  blockers block the ATIIR. There is evidence for activation of the RAAS in ADPKD
  patients.ACE: Angiotensin-converting enzyme; AGT1: Angiotensin 1; ARB: Angiotensin
  receptor blocker; ATIIR: Angiotensin II receptor; Ca2+: Intracellular calcium; cAMP:
  Cyclic adenosine monophosphate; CDK: Cyclin-dependent kinase; CFTR: Cystic fibrosis
  transmembrane conductance regulator; EGF: Epidermal growth factor; ERK: Extracellular
  signal-regulated kinase; FKBP: FK506 binding protein; Gi,Gs: G protein; HMG-CoAR:
  3-hydroxy-3-methyl-glutaryl-CoA reductase; IGF: Insulin-like growth factor; JGA:
  Juxtaglomerular apparatus; MAPK: Mitogen–activated protein kinase; MEK: Maperk kinase;
  mTOR: Mammalian target of rapamycin; PI3K: Phosphoinositide 3-kinase; PC1: Polycystin1;
  PC2: Polycystin2; PDE: Phosphodiesterase; PKA: Protein kinase A; Rheb: Ras homolog
  enriched in brain; Src: Sarcoma; SSTR: Somatostatin receptor; TKI: Tyrosine kinase
  inhibitor; TNF: Tumor necrosis factor; V2R: Vasopressin v2 receptor; VEGF: Vascular
  endothelial growth factor.'
pmcid: PMC2861144
papertitle: Novel targets for the treatment of autosomal dominant polycystic kidney
  disease.
reftext: Franck A Belibi, et al. Expert Opin Investig Drugs. ;19(3):315-328.
pmc_ranked_result_index: '137312'
pathway_score: 0.9648557
filename: nihms195501f1.jpg
figtitle: Novel targets for the treatment of autosomal dominant polycystic kidney
  disease
year: ''
organisms:
- Homo sapiens
ndex: d2c5deba-ded3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2861144__nihms195501f1.html
  '@type': Dataset
  description: 'Potential targets for inhibition are depicted in light gray boxes.
    Potential inhibitors are depicted in clear boxes. The cAMP pathway promotes cell
    proliferation and fluid secretion in PKD. cAMP leads to fluid secretion via the
    CFTR. cAMP results in activation of the ERK-MAPK pathway leading to cell proliferation.
    cAMP accumulation is promoted by mechanisms of dysregulation of PC1 or PC2, as
    well as inhibition of Ca2+-dependent phosphodiesterase (PDE). Caffeine inhibits
    PDE, which normally degrades cAMP. Thus, caffeine results in an increase in cAMP.
    cAMP signaling also requires PKA, Src and Ras. Src is known to activate Ras. Activation
    of tyrosine kinase receptors also contributes to the stimulation of MAPK-ERK signaling
    with consequent cell proliferation. Potential therapeutic targets are the vasopressin
    V2 receptor, tyrosine kinases, MEK and c-Src. The PI3K-Akt pathway plays a major
    role in mTOR signaling (see ); mTOR inhibitors bind to FKBP, which subsequently
    inhibits mTOR. There is evidence for activation of the mTOR pathway in ADPKD.
    The RAAS (see ) is activated by a drop in renal perfusion that stimulates the
    JGA to make renin. ACE inhibitors block the conversion of angiotensin I to angiotensin
    II. Renin inhibitors directly block renin production by the JGA. Angiotensin receptor
    blockers block the ATIIR. There is evidence for activation of the RAAS in ADPKD
    patients.ACE: Angiotensin-converting enzyme; AGT1: Angiotensin 1; ARB: Angiotensin
    receptor blocker; ATIIR: Angiotensin II receptor; Ca2+: Intracellular calcium;
    cAMP: Cyclic adenosine monophosphate; CDK: Cyclin-dependent kinase; CFTR: Cystic
    fibrosis transmembrane conductance regulator; EGF: Epidermal growth factor; ERK:
    Extracellular signal-regulated kinase; FKBP: FK506 binding protein; Gi,Gs: G protein;
    HMG-CoAR: 3-hydroxy-3-methyl-glutaryl-CoA reductase; IGF: Insulin-like growth
    factor; JGA: Juxtaglomerular apparatus; MAPK: Mitogen–activated protein kinase;
    MEK: Maperk kinase; mTOR: Mammalian target of rapamycin; PI3K: Phosphoinositide
    3-kinase; PC1: Polycystin1; PC2: Polycystin2; PDE: Phosphodiesterase; PKA: Protein
    kinase A; Rheb: Ras homolog enriched in brain; Src: Sarcoma; SSTR: Somatostatin
    receptor; TKI: Tyrosine kinase inhibitor; TNF: Tumor necrosis factor; V2R: Vasopressin
    v2 receptor; VEGF: Vascular endothelial growth factor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GNAZ
  - CDK12
  - PDE10A
  - CDK18
  - PDE3A
  - CDK17
  - GNAT2
  - PDE11A
  - IGF1
  - CDK16
  - GNAT3
  - PKD2
  - CDKL3
  - PDE7B
  - JUN
  - CDK19
  - PRKACB
  - MYC
  - PRKACG
  - PDE4D
  - GNAI1
  - PRKAR1A
  - GNAT1
  - CDK15
  - PDE1A
  - AKT2
  - MTOR
  - CDK20
  - RPS6KB2
  - PCSK1
  - CDKL4
  - TSC2
  - GNAO1
  - CDK1
  - CDK11B
  - CDK2
  - GNAS
  - GNAL
  - PDE1C
  - PDE2A
  - PDE3B
  - RPS6KB1
  - AVPR2
  - PDE4B
  - GNAI2
  - PDE4C
  - AKT3
  - AKT1
  - PDE6A
  - CDK3
  - CDK14
  - MAP2K1
  - MAP2K2
  - CDK8
  - CDK9
  - TNF
  - PRKAR1B
  - TSC1
  - AGXT2
  - MAPK1
  - MAPK3
  - VEGFC
  - MFAP1
  - CDK4
  - CDK5
  - CDKL5
  - CDK11A
  - CDK10
  - PDE4A
  - CDK13
  - CDKL1
  - ACE
  - VEGFD
  - PGF
  - VEGFA
  - CFTR
  - BRAF
  - PRKACA
  - NRAS
  - KRAS
  - RHEB
  - SRC
  - PRKAR2B
  - GNAI3
  - VEGFB
  - PDE6C
  - CDK7
  - HRAS
  - PDE9A
  - CDK6
  - CDKL2
  - PDE8B
  - PRKAR2A
  - CCND2
  - PDE1B
  - PDE6B
  - PDE7A
  - EGF
  - CCND3
  - PDE8A
  - CCND1
  - Triptolide
  - aliskiren
  - Caffeine
  - Chloride
  - losartan
  - Cancer
  - Melanoma
genes:
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAZ
  entrez: '2781'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK12
  entrez: '51755'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE10A
  entrez: '10846'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK18
  entrez: '5129'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE3A
  entrez: '5139'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK17
  entrez: '5128'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAT2
  entrez: '2780'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE11A
  entrez: '50940'
- word: IGF1,
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK16
  entrez: '5127'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAT3
  entrez: '346562'
- word: PC2
  symbol: Pc-2
  source: hgnc_alias_symbol
  hgnc_symbol: PKD2
  entrez: '5311'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL3
  entrez: '51265'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE7B
  entrez: '27115'
- word: Jun
  symbol: JUN
  source: hgnc_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK19
  entrez: '23097'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4D
  entrez: '5144'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAI1
  entrez: '2770'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAT1
  entrez: '2779'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK15
  entrez: '65061'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1A
  entrez: '5136'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK20
  entrez: '23552'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: PC1,
  symbol: PC1
  source: hgnc_alias_symbol
  hgnc_symbol: PCSK1
  entrez: '5122'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL4
  entrez: '344387'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAO1
  entrez: '2775'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK1
  entrez: '983'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK11B
  entrez: '984'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: Gs
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAS
  entrez: '2778'
- word: Gs
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAL
  entrez: '2774'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1C
  entrez: '5137'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE2A
  entrez: '5138'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE3B
  entrez: '5140'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: V2R
  symbol: V2R
  source: hgnc_alias_symbol
  hgnc_symbol: AVPR2
  entrez: '554'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4B
  entrez: '5142'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAI2
  entrez: '2771'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4C
  entrez: '5143'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6A
  entrez: '5145'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK3
  entrez: '1018'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK14
  entrez: '5218'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK8
  entrez: '1024'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK9
  entrez: '1025'
- word: TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: TSC1
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: AGTII
  symbol: AGT2
  source: hgnc_alias_symbol
  hgnc_symbol: AGXT2
  entrez: '64902'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: EGF,IGF1,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK5
  entrez: '1020'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL5
  entrez: '6792'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK11A
  entrez: '728642'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK10
  entrez: '8558'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4A
  entrez: '5141'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK13
  entrez: '8621'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL1
  entrez: '8814'
- word: Ace
  symbol: ACE
  source: hgnc_symbol
  hgnc_symbol: ACE
  entrez: '1636'
- word: EGF,IGF1,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: EGF,IGF1,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: EGF,IGF1,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: CFTR
  symbol: CFTR
  source: hgnc_symbol
  hgnc_symbol: CFTR
  entrez: '1080'
- word: B-raf
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAI3
  entrez: '2773'
- word: EGF,IGF1,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6C
  entrez: '5146'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK7
  entrez: '1022'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE9A
  entrez: '5152'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL2
  entrez: '8999'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE8B
  entrez: '8622'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1B
  entrez: '5153'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6B
  entrez: '5158'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE7A
  entrez: '5150'
- word: EGF,
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE8A
  entrez: '5151'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
chemicals:
- word: Triptolide
  source: MESH
  identifier: C001899
- word: aliskiren
  source: MESH
  identifier: C446481
- word: Caffeine
  source: MESH
  identifier: D002110
- word: Chloride
  source: MESH
  identifier: D002712
- word: losartan
  source: MESH
  identifier: D019808
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Melanoma
  source: ''
  identifier: ''
figid_alias: PMC2861144__F1
redirect_from: /figures/PMC2861144__F1
figtype: Figure
---
